Results 241 to 250 of about 3,763,730 (308)
ABSTRACT Background The Ideal Outcome is a composite quality indicator reflecting optimal postoperative course after pancreatic surgery. This study aimed to clarify the prognostic significance of achieving the Ideal Outcome and its influence on the initiation and completion of adjuvant chemotherapy.
Ryosuke Fukushima +9 more
wiley +1 more source
ABSTRACT Aim In Japan, the National Clinical Database (NCD), a clinician‐reported registry, and the National Database of Health Insurance Claims and Specific Health Checkups of Japan Open Data (NDB Open Data), an administrative claims database, are both widely used as nationwide surgical databases, but their consistency in capturing national surgical ...
Atomu Kiriyama +3 more
wiley +1 more source
Innovative pathological and therapeutic approaches for poorly cohesive gastric cancer. [PDF]
Muratore M +9 more
europepmc +1 more source
This nationwide observational study used data from the National Clinical Database. Patients who underwent total or distal gastrectomy for gastric cancer after chemotherapy between January 2014 and December 2022 were included. Minimally invasive surgery was associated with lower incidences of overall postoperative complications of Clavien–Dindo grade ...
Nobuaki Hoshino +8 more
wiley +1 more source
Delayed Cutaneous Metastases From Gastric Cancer: 20 Years Later. [PDF]
Ogiwara S, Furihata M, Osada T.
europepmc +1 more source
ABSTRACT Small intestinal bacterial overgrowth (SIBO) has recently gained increasing attention as a potential cause of postoperative gastrointestinal symptoms following gastrointestinal cancer surgery. Surgical procedures can disrupt normal gastrointestinal physiology through anatomical reconstruction, impaired motility, reduced gastric acid secretion,
Toru Aoyama +2 more
wiley +1 more source
Advances in the molecular subtyping of gastric cancer. [PDF]
Chen J, Zhang X, Zhao Y.
europepmc +1 more source
Prospectively determined clinical T and N categories clearly stratified long‐term survival in locally advanced gastric cancer. Patients with cT3N+, cT4aN0, cT4aN+, and cT4b disease showed unfavorable prognosis despite standard treatment. These findings may help optimize patient selection for perioperative treatment strategies.
Tsutomu Hayashi +19 more
wiley +1 more source
Gastric Juice microRNAs in Gastric Cancer: What is the Evidence? [PDF]
Kyrochristou GD +6 more
europepmc +1 more source

